S&P 500 jumps as AMD rally leads tech higher
Investing.com - Stereotaxis reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Stereotaxis announced earnings per share of $-0.070 on revenue of $7.66M. Analysts polled by Investing.com EPS of $-0.059 on revenue of $8.3M.
Stereotaxis 's are down 4.96% and is trading at $1.890 , still down 73.82% from its 52 week high of $7.22 set on Wednesday, January 5, 2022.
Stereotaxis shares gained 9.88% to trade at $1.890 in intra-day trade the report.
Stereotaxis follows other major Healthcare sector earnings this month
Stereotaxis's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar